Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 4/20 | 0.43 |
| ▸ | ESR2 | Q92731 | 4/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | KIF11 | P52732 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24368694 | 0.87 | ESR1 (0.36) | ESR1ESR2ALDH1A1KIF11KDM4E | |
| SCHEMBL24368497 | 0.87 | ESR1 (0.36) | ESR1ESR2ALDH1A1KIF11KDM4E | |
| SCHEMBL24369027 | 0.87 | ESR1 (0.36) | ESR1ESR2ALDH1A1KIF11KDM4E | |
| SCHEMBL13475650 | 0.86 | ESR1 (0.35) | ESR1ESR2LMNAALDH1A1KDM4E | |
| SCHEMBL24368502 | 0.85 | ALDH1A1 (0.35) | ESR1ESR2LMNAALDH1A1KDM4E | |
| SCHEMBL22214695 | 0.81 | ESR1 (0.36) | ESR1ESR2LMNAALDH1A1KDM4E | |
| SCHEMBL24368499 | 0.78 | ESR1 (0.35) | ESR1ESR2ALDH1A1KDM4EMEN1 | |
| SCHEMBL24368695 | 0.78 | ESR1 (0.35) | ESR1ESR2ALDH1A1KDM4EMEN1 | |
| SCHEMBL13475657 | 0.78 | ESR1 (0.34) | ESR1ESR2 | |
| SCHEMBL16482577 | 0.78 | LMNA (0.37) | LMNAKDM4EMEN1MAPTOPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115776981-A | Material for organic electroluminescent device | 默克专利有限公司 | 2023-03-10 | — | — | CN | claimed |
| US-20220416164-A1 | NITROGEN-CONTAINING COMPOUNDS, ELECTRONIC ELEMENTS AND ELECTRONIC DEVICES | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2022-12-29 | — | — | US | claimed |
| CN-115087654-A | Material for organic electroluminescent device | 默克专利有限公司 | 2022-09-20 | — | — | CN | claimed |
| CN-114787173-A | Metal complexes | 默克专利有限公司 | 2022-07-22 | — | — | CN | claimed |
| CN-114516803-A | Fused ring compound and application thereof | 宁波卢米蓝新材料有限公司 | 2022-05-20 | — | — | CN | claimed |
| CN-111902409-A | Compound, material for organic electroluminescent element, and electronic device | 出光兴产株式会社 | 2020-11-06 | — | — | CN | claimed |
| CN-111788177-A | Spirobenzanthracene-fluorene derivatives and their use in organic electronic devices, display and lighting devices | 诺瓦尔德股份有限公司 | 2020-10-16 | — | — | CN | claimed |
| CN-111770922-A | Organic electronic device, display and lighting apparatus including the same | 诺瓦尔德股份有限公司 | 2020-10-13 | — | — | CN | claimed |
| CN-111683948-A | Phenanthroline compound and organic light emitting device including the same | 株式会社进雄产业 | 2020-09-18 | — | — | CN | claimed |
| CN-111564567-A | Organic light emitting element | 三星显示有限公司 | 2020-08-21 | — | — | CN | claimed |
| CN-111417639-A | Material for organic electroluminescent device | 默克专利有限公司 | 2020-07-14 | — | — | CN | claimed |
| EP-1422225-B1 | BENZOISOSELENAZOLE DERIVATIVES WITH ANTI-INFLAMMATION, ANTINEOPLASTIC AND ANTI-THROMBOSIS ACTIVITY AND THEIR USE | UNIV BEIJING (CN) | 2012-01-04 | — | — | EP | claimed |
| US-20090117204-A1 | BENZOISOSELENAZOLE DERIVATIVES WITH ANTI-INFLAMMATION, ANTIVIRUS AND ANTITHROMBOSIS ACTIVITY AND THEIR USE | PEKING UNIVERSITY (CN) | 2009-05-07 | — | — | US | claimed |
| US-7495019-B2 | Benzoisoselenazole derivatives with anti-inflammation, antivirus and antithrombosis activity and their use | PEKING UNIVERSITY (CN) | 2009-02-24 | — | — | US | claimed |
| US-20050014801-A1 | Benzoisoselenazole derivatives with anti-inflammation, antivirus and antithrombosis activity and their use | PEKING UNIVERSITY (CN) | 2005-01-20 | — | — | US | claimed |
| EP-1422225-A1 | BENZOISOSELENAZOLE DERIVATIVES WITH ANTI-INFLAMMATION, ANTIVIRUS AND ANTI-THROMBOSIS ACTIVITY AND THEIR USE | Peking University (CN) | 2004-05-26 | — | — | EP | claimed |
| CN-110036498-B | Method for manufacturing electronic device | 默克专利有限公司 | 2023-04-18 | — | — | CN | disclosed |
| CN-115956073-A | Material for organic electroluminescent device | 默克专利有限公司 | 2023-04-11 | — | — | CN | disclosed |
| US-20050014801-A1 | Benzoisoselenazole derivatives with anti-inflammation, antivirus and antithrombosis activity and their use | PEKING UNIVERSITY (CN) | 2005-01-20 | — | — | US | disclosed |
| EP-1422225-A1 | BENZOISOSELENAZOLE DERIVATIVES WITH ANTI-INFLAMMATION, ANTIVIRUS AND ANTI-THROMBOSIS ACTIVITY AND THEIR USE | Peking University (CN) | 2004-05-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090117204-A1 | BENZOISOSELENAZOLE DERIVATIVES WITH ANTI-INFLAMMATION, ANTIVIRUS AND ANTITHROMBOSIS ACTIVITY AND THEIR USE | SERPINC1, IL33, SERPINB1 | ESR1 1935/4885ESR2 1552/4885LMNA 2721/4885 |
| US-20050014801-A1 | Benzoisoselenazole derivatives with anti-inflammation, antivirus and antithrombosis activity and their use | SERPINC1, IL33, SERPINB1 | ESR1 1935/4885ESR2 1552/4885LMNA 2721/4885 |
| US-20220416164-A1 | NITROGEN-CONTAINING COMPOUNDS, ELECTRONIC ELEMENTS AND ELECTRONIC DEVICES | NPPA, NES, INA | ESR1 32/4885ESR2 265/4885LMNA 1408/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.